News Focus
News Focus
icon url

CrashOverride

10/15/22 6:29 PM

#522193 RE: Grip it and Sip It #522191

The company didn't release TLD. As I stated they are following NEJM media embargo policy which doesn't allow the company to publish TLD, since the journal must have exclusivity on publication, but they can share it with regulators, investigators who are not company employees can present it at scientific meetings, and finally patient advocacy groups can publish it on their websites. This allows the data to get out there among experts in the field though the general public isn't made aware of it until the media embargo gets lifted. At that point the company can send out their TLR PR which will hit the Bloomberg Terminal.
icon url

JerryCampbell

10/15/22 6:29 PM

#522194 RE: Grip it and Sip It #522191

100% correct.
icon url

biosectinvestor

10/16/22 3:38 AM

#522231 RE: Grip it and Sip It #522191

There is a difference here. There was no ”release” and the company has said nothing about meeting endpoints. What you heard was the presentations of third-party scientists who ran the trial. No one has seen the slides or the video of those presentations anywhere else but on a third-party charitable website and on the original forum website, and yet a critic like Adam Fuerstein wants to imply The Company committed fraud or did x,y or x. The facts are different than these critics want to say, but boy do they scream and repeat the false narratives, over and over. They’re so frustrated because it makes them liars.

But the company has announced nothing. Only scientists…who don’t work for the company. Their value is they are independent. They work for research universities, and their value to them and the world, their most valuable commodity is their reputations.

Endpoints were discussed and some data, in those presentation, but not a publication with more than just those highlights. A publication will provide fuller data and analysis.

We know NWBO is still observing an embargo on release of such information. The company never released the endpoints or any discussion thereof in a press release nor have they ever given a press interview.

The answer, therefore is quite obvious, even if some critics want to insist otherwise. People have their agendas, but facts are facts.